Holders over time
- TMO
- GILD
| Quarter | TMO | GILD |
|---|---|---|
| Q4 2020 | 33 holders, $39.2bn | 27 holders, $13.4bn |
| Q1 2021 | 35 holders, $36.5bn | 24 holders, $14.5bn |
| Q2 2021 | 33 holders, $38.3bn | 18 holders, $14.9bn |
| Q3 2021 | 32 holders, $42.6bn | 20 holders, $16.4bn |
| Q4 2021 | 38 holders, $50.1bn | 20 holders, $16.8bn |
| Q1 2022 | 32 holders, $43.2bn | 28 holders, $13.2bn |
| Q2 2022 | 33 holders, $38.9bn | 26 holders, $13.6bn |
| Q3 2022 | 26 holders, $34.3bn | 24 holders, $13.3bn |
| Q4 2022 | 29 holders, $37.0bn | 32 holders, $21.1bn |
| Q1 2023 | 35 holders, $37.1bn | 27 holders, $21.8bn |
| Q2 2023 | 39 holders, $33.5bn | 24 holders, $20.7bn |
| Q3 2023 | 39 holders, $32.6bn | 24 holders, $20.0bn |
| Q4 2023 | 41 holders, $32.7bn | 22 holders, $21.5bn |
| Q1 2024 | 30 holders, $34.1bn | 30 holders, $20.3bn |
| Q2 2024 | 38 holders, $30.6bn | 28 holders, $18.5bn |
| Q3 2024 | 30 holders, $33.8bn | 29 holders, $24.2bn |
| Q4 2024 | 36 holders, $27.6bn | 28 holders, $25.9bn |
| Q1 2025 | 31 holders, $24.2bn | 33 holders, $32.0bn |
| Q2 2025 | 39 holders, $18.8bn | 27 holders, $30.9bn |
| Q3 2025 | 32 holders, $21.9bn | 23 holders, $29.4bn |
| Q4 2025 | 32 holders, $29.9bn | 25 holders, $34.3bn |
| Q1 2026 | 34 holders, $24.4bn | 25 holders, $38.5bn |
| Q2 2026 | 36 holders, $26.4bn | 26 holders, $34.2bn |
| Q3 2026 | 35 holders, $40.3bn | 31 holders, $38.6bn |
Thermo Fisher Scientific Inc
- Holders
- 31
- Reported value
- $24.2bn
- Buyers
- 12
- Sellers
- 22
Breadth -10 among 95 comparable managers.
Gilead Sciences Inc
- Holders
- 33
- Reported value
- $32.0bn
- Buyers
- 21
- Sellers
- 12
Breadth +9 among 95 comparable managers.
Who holds both, Q1 2025
Both (17)
Acadian Asset Management LLC, AllianceBernstein LP, AQR Capital Management LLC, Capital Research Global Investors, Capital World Investors, D. E. Shaw & Co., Dodge & Cox, Fidelity (FMR LLC), Invesco Ltd, Janus Henderson Group Ltd, Millennium Management LLC, Neuberger Berman Group LLC, Point72 Asset Management LP, Renaissance Technologies LLC, T. Rowe Price Associates Inc, Verition Fund Management LLC, Wellington Management Group LLP
Only TMO (14)
Arrowstreet Capital LP, Baillie Gifford & Co, Farallon Capital Management LLC, GAMCO Investors Inc, Markel Group Inc, MFS Investment Management, Polen Capital Management LLC, Quantbot Technologies LP, Rokos Capital Management LLP, Squarepoint Ops LLC, Tudor Investment Corp, Two Sigma Advisers LP, Two Sigma Investments LP, Walleye Capital LLC
Only GILD (16)
Balyasny Asset Management LLC, Brevan Howard Capital Management LP, Bridgewater Associates LP, Caxton Associates LLP, Citadel Advisors LLC, Element Capital Management LLC, ExodusPoint Capital Management LP, Holocene Advisors LP, Hudson Bay Capital Management LP, Jane Street Group LLC, Man Group PLC, Marshall Wace LLP, PDT Partners LLC, Schonfeld Strategic Advisors LLC, Voloridge Investment Management LLC, Woodline Partners LP
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.